Nanjing Hicin Pharmaceutical Co., Ltd. (300584) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Nanjing Hicin Pharmaceutical Co., Ltd.

Why is Nanjing Hicin Pharmaceutical Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 4.33%

The company has been able to generate a Return on Capital Employed (avg) of 4.33% signifying low profitability per unit of total capital (equity and debt)

Poor long term growth as Net Sales has grown by an annual rate of -0.39% and Operating profit at 5.03% over the last 5 years

Positive results in Mar 26

NET SALES(HY) At CNY 359.86 MM has Grown at 25.6%
NET PROFIT(HY) At CNY 42.3 MM has Grown at 55.88%
DEBT-EQUITY RATIO (HY) Lowest at 21.01 %

With ROE of 5.39%, it has a expensive valuation with a 1.87 Price to Book Value

Over the past year, while the stock has generated a return of -6.56%, its profits have risen by 38% ; the PEG ratio of the company is 0.9
At the current price, the company has a high dividend yield of 0.3

Underperformed the market in the last 1 year

Even though the market (China Shanghai Composite) has generated returns of 16.83% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -6.56% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Nanjing Hicin Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Nanjing Hicin Pharmaceutical Co., Ltd.

-47.26%

2.02

71.93%

China Shanghai Composite

3.23%

1.20

14.07%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-0.39%

EBIT Growth (5y)

5.03%

EBIT to Interest (avg)

6.40

Debt to EBITDA (avg)

1.80

Net Debt to Equity (avg)

0.25

Sales to Capital Employed (avg)

0.42

Tax Ratio

7.88%

Dividend Payout Ratio

28.53%

Pledged Shares

Institutional Holding

ROCE (avg)

3.91%

ROE (avg)

4.12%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.93

EV to EBIT

57.01

EV to EBITDA

34.61

EV to Capital Employed

3.42

EV to Sales

6.43

PEG Ratio

1.92

Dividend Yield

0.15%

ROCE (Latest)

6.00%

ROE (Latest)

5.39%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

Mildly Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

INTEREST COVERAGE RATIO(Q)

Highest at 3,728.52

NET PROFIT(9M)

Higher at CNY 57.01 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 2.57 times

DEBTORS TURNOVER RATIO(HY)

Highest at 3.1 times

NET SALES(Q)

Highest at CNY 203.81 MM

-3What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 11.57 MM

RAW MATERIAL COST(Y)

Grown by 19.56% (YoY

Here's what is working for Nanjing Hicin Pharmaceutical Co., Ltd.

Interest Coverage Ratio

Highest at 3,728.52

in the last five periods

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales

Highest at CNY 203.81 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 203.81 MM has Grown at 18.37%

over average net sales of the previous four periods of CNY 172.18 MM

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Inventory Turnover Ratio

Highest at 2.57 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 3.1 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Net Profit

Higher at CNY 57.01 MM

than preceding 12 month period ended Jun 2026

MOJO Watch

In the nine month period the company has already crossed sales of the previous twelve months

Net Profit (CNY MM)

Here's what is not working for Nanjing Hicin Pharmaceutical Co., Ltd.

Operating Cash Flow

Lowest at CNY 11.57 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Raw Material Cost

Grown by 19.56% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales